Sargent Bickham Lagudis’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $4.15K | Buy |
+50
| New | +$4.15K | ﹤0.01% | 825 |
|
|
2022
Q2 | – | Sell |
-100
| Closed | -$9K | – | 1150 |
|
|
2022
Q1 | $9K | Hold |
100
| – | – | ﹤0.01% | 735 |
|
|
2021
Q4 | $11K | Hold |
100
| – | – | ﹤0.01% | 703 |
|
|
2021
Q3 | $13K | Hold |
100
| – | – | ﹤0.01% | 682 |
|
|
2021
Q2 | $14K | Hold |
100
| – | – | ﹤0.01% | 668 |
|
|
2021
Q1 | $14K | Hold |
100
| – | – | ﹤0.01% | 645 |
|
|
2020
Q4 | $14K | Buy |
100
+15
| +18% | +$2.1K | ﹤0.01% | 614 |
|
|
2020
Q3 | $9K | Buy |
85
+20
| +31% | +$2.12K | ﹤0.01% | 612 |
|
|
2020
Q2 | $7K | Buy |
65
+30
| +86% | +$3.23K | ﹤0.01% | 619 |
|
|
2020
Q1 | $3K | Buy |
+35
| New | +$3K | ﹤0.01% | 689 |
|
|
2018
Q4 | – | Sell |
-1,647
| Closed | -$158K | – | 808 |
|
|
2018
Q3 | $158K | Hold |
1,647
| – | – | 0.02% | 228 |
|
|
2018
Q2 | $157K | Hold |
1,647
| – | – | 0.02% | 228 |
|
|
2018
Q1 | $144K | Hold |
1,647
| – | – | 0.02% | 244 |
|
|
2017
Q4 | $140K | Hold |
1,647
| – | – | 0.02% | 250 |
|
|
2017
Q3 | $143K | Hold |
1,647
| – | – | 0.02% | 248 |
|
|
2017
Q2 | $127K | Hold |
1,647
| – | – | 0.02% | 245 |
|
|
2017
Q1 | $114K | Hold |
1,647
| – | – | 0.01% | 259 |
|
|
2016
Q4 | $97K | Hold |
1,647
| – | – | 0.02% | 266 |
|
|
2016
Q3 | $109 | Hold |
1,647
| – | – | 0.02% | 262 |
|
|
2016
Q2 | $89K | Hold |
1,647
| – | – | 0.01% | 279 |
|
|
2016
Q1 | $85K | Buy |
+1,647
| New | +$85K | 0.01% | 291 |
|